| Mutational spectrum, copy number changes, and outcome: results of a sequencing study of patients with newly diagnosed myeloma BA Walker, EM Boyle, CP Wardell, A Murison, DB Begum, NM Dahir, ... Journal of clinical oncology 33 (33), 3911-3920, 2015 | 637 | 2015 |
| The spectrum of somatic mutations in monoclonal gammopathy of undetermined significance indicates a less complex genomic landscape than that in multiple myeloma A Mikulasova, CP Wardell, A Murison, EM Boyle, GH Jackson, J Smetana, ... Haematologica 102 (9), 1617, 2017 | 109 | 2017 |
| Severe type I interferonopathy and unrestrained interferon signaling due to a homozygous germline mutation in STAT2 CJA Duncan, BJ Thompson, R Chen, GI Rice, F Gothe, DF Young, ... Science immunology 4 (42), eaav7501, 2019 | 99 | 2019 |
| Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entities B Oben, G Froyen, KH Maclachlan, D Leongamornlert, F Abascal, ... Nature communications 12 (1), 1861, 2021 | 86 | 2021 |
| Germline TET2 loss of function causes childhood immunodeficiency and lymphoma J Stremenova Spegarova, D Lawless, SMB Mohamad, KR Engelhardt, ... Blood, The Journal of the American Society of Hematology 136 (9), 1055-1066, 2020 | 72 | 2020 |
| Microhomology-mediated end joining drives complex rearrangements and overexpression of MYC and PVT1 in multiple myeloma A Mikulasova, C Ashby, RG Tytarenko, P Qu, A Rosenthal, JA Dent, ... Haematologica 105 (4), 1055, 2020 | 55 | 2020 |
| A de novo paradigm for male infertility MS Oud, RM Smits, HE Smith, FK Mastrorosa, GS Holt, BJ Houston, ... Nature communications 13 (1), 154, 2022 | 54 | 2022 |
| Genomewide profiling of copy‐number alteration in monoclonal gammopathy of undetermined significance A Mikulasova, J Smetana, M Wayhelova, H Janyskova, V Sandecka, ... European journal of haematology 97 (6), 568-575, 2016 | 35 | 2016 |
| Genome‐wide screening of cytogenetic abnormalities in multiple myeloma patients using array‐CGH technique: a Czech multicenter experience J Smetana, J Frohlich, R Zaoralova, V Vallova, H Greslikova, R Kupska, ... BioMed research international 2014 (1), 209670, 2014 | 35 | 2014 |
| Gain (1)(q21) is an unfavorable genetic prognostic factor for patients with relapsed multiple myeloma treated with thalidomide but not for those treated with bortezomib J Smetana, K Berankova, R Zaoralova, P Nemec, H Greslikova, R Kupska, ... Clinical Lymphoma Myeloma and Leukemia 13 (2), 123-130, 2013 | 31 | 2013 |
| Dynamics of broad H3K4me3 domains uncover an epigenetic switch between cell identity and cancer-related genes M Belhocine, M Simonin, JDA Flores, A Cieslak, I Manosalva, L Pradel, ... Genome Research 32 (7), 1328-1342, 2022 | 18 | 2022 |
| A first Czech analysis of 1887 cases with monoclonal gammopathy of undetermined significance V Sandecká, R Hájek, L Pour, I Špička, V Ščudla, E Gregora, J Radocha, ... European journal of haematology 99 (1), 80-90, 2017 | 14 | 2017 |
| Broad H3K4me3 domains: Maintaining cellular identity and their implication in super‐enhancer hijacking D Kent, L Marchetti, A Mikulasova, LJ Russell, D Rico Bioessays 45 (10), 2200239, 2023 | 11 | 2023 |
| Epigenomic translocation of H3K4me3 broad domains over oncogenes following hijacking of super-enhancers A Mikulasova, D Kent, M Trevisan-Herraz, N Karataraki, KTM Fung, ... Genome Research 32 (7), 1343-1354, 2022 | 11 | 2022 |
| Structural variants shape the genomic landscape and clinical outcome of multiple myeloma C Ashby, EM Boyle, MA Bauer, A Mikulasova, CP Wardell, L Williams, ... Blood Cancer Journal 12 (5), 85, 2022 | 11 | 2022 |
| Prediction of progression of smouldering into therapy requiring multiple myeloma by easily accessible clinical factors [in 527 patients] R Hajek, V Sandecka, A Seckinger, I Spicka, V Scudla, E Gregora, ... Blood, The Journal of the American Society of Hematology 124 (21), 2071-2071, 2014 | 11 | 2014 |
| Molecular characterization and clinical outcome of B-cell precursor acute lymphoblastic leukemia with IG-MYC rearrangement S Bomken, A Enshaei, EC Schwalbe, A Mikulasova, Y Dai, M Zaka, ... Haematologica 108 (3), 717, 2023 | 9 | 2023 |
| High-resolution simulations of chromatin folding at genomic rearrangements in malignant B cells provide mechanistic insights into proto-oncogene deregulation D Rico, D Kent, N Karataraki, A Mikulasova, R Berlinguer-Palmini, ... Genome Research 32 (7), 1355-1366, 2022 | 8 | 2022 |
| Chromothripsis and chromoplexy are associated with DNA instability and adverse clinical outcome in multiple myeloma C Ashby, MA Bauer, Y Wang, CP Wardell, RG Tytarenko, P Patel, E Flynt, ... Blood 132, 408, 2018 | 7 | 2018 |
| GATA2 deficiency phenotype associated with tandem duplication of GATA2 and overexpression of GATA2-AS1 P Singh, M Heer, A Resteu, A Mikulasova, M Reza, L Largeaud, ... Blood advances 5 (24), 5631-5635, 2021 | 6 | 2021 |
